Form 4: Verrica Pharmaceuticals Director Transfers Shares to Family Trusts

Paul B. Manning, a director and 10% owner of Verrica Pharmaceuticals, transferred shares to family trusts following the termination of a Grantor Retained Annuity Trust.

Summary

• On September 19, 2024, Paul B. Manning, a director of Verrica Pharmaceuticals, transferred 2,675,611.25 shares of common stock to trusts for the benefit of his immediate family members upon the termination of a Grantor Retained Annuity Trust.
• He also acquired 891,870.41 shares in one trust and 891,870.42 shares each in three other trusts for family members.
• Manning directly owns 7,851,128 shares and indirectly owns shares through various entities and trusts.
• He disclaims beneficial ownership of shares held by family trusts, with his spouse as trustee.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a transfer of shares for estate planning purposes. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

This filing reflects insider transactions related to estate planning and family wealth transfer, which are common activities among corporate executives and large shareholders. It doesn't necessarily indicate a change in the company's fundamentals or outlook.

Stakeholder Impact

• The transfer of shares to family trusts may have a minor impact on the ownership structure of Verrica Pharmaceuticals.
• However, since the Reporting Person disclaims beneficial ownership of these securities, the impact is likely minimal.

Key Dates